Provided by Tiger Trade Technology Pte. Ltd.

Acrivon Therapeutics, Inc.

2.04
+0.05002.51%
Post-market: 2.040.00000.00%19:30 EDT
Volume:323.97K
Turnover:652.11K
Market Cap:87.31M
PE:-1.09
High:2.06
Open:2.03
Low:1.96
Close:1.99
52wk High:3.56
52wk Low:1.27
Shares:42.80M
Float Shares:25.69M
Volume Ratio:2.02
T/O Rate:1.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8800
EPS(LYR):-2.0151
ROE:-64.63%
ROA:-38.02%
PB:1.01
PE(LYR):-1.01

Loading ...

May 14, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 25, 2024

Correspondence

Form CORRESP - Correspondence
Apr 25, 2024

Major Issues Report

Form 8-K - Current report
Apr 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Apr 11, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Apr 09, 2024

Major Issues Report

Form 8-K - Current report
Mar 29, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 28, 2024

Major Issues Report

Form 8-K - Current report
Mar 28, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 04, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Dec 13, 2023

Correspondence

Form CORRESP - Correspondence
Dec 08, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]